Lataa...
Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
High-grade gliomas are the most threatening brain tumors due to aggressive proliferation and poor prognosis. Thus, utilizing genetic glioma biomarkers to forecast prognosis and guide clinical management is crucial. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (PLOD3) modulates cancer progressi...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5884658/ https://ncbi.nlm.nih.gov/pubmed/29644003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24594 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|